People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Other Health Care, SaaS / Software, Pharma, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cortica Inc. | — | Other Health Care | Series D+ | $210.9M | $757.8M | 2023 |
| Cortex, Inc. | — | SaaS / Software | Series D+ | $133.4M | $1.9B | 2023 |
| Spirox, Inc. | — | Other Health Care | Series C | $98.2M | $1.0B | 2015 |
| Advanced Cardiac Therapeutics Inc | — | Pharma | Series C | $64.1M | $1.6B | 2014 |
| Serpex Medical Inc. | — | Biotechnology | Seed | $4.6M | $40.4M | 2020 |
| Mimosa Medical, Inc. | — | Other | Seed | $2.2M | $8.3M | 2014 |
| Verix Health, Inc. | — | Biotechnology | Seed | $1.5M | $66.6M | 2019 |
| Atriomx, Inc. | — | Other | Pre-Seed | $1.0M | $18.0M | 2021 |
Doug Koo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Doug Koo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Duke Rohlen | 6 | 10 |
| Aftab Kherani | 4 | 9 |
| Ryan Drant | 2 | 24 |
| Anthony J. Natale | 2 | 5 |
| Tony Natale | 2 | 5 |
| Sasha Schrode | 2 | 2 |
| Roy Tanaka | 1 | 6 |
| Justin Klein | 1 | 6 |
| Richard B. Emmitt | 1 | 6 |
| Camille Samuels | 1 | 6 |
| Avi Naider | 1 | 6 |
| STACY ENXING SENG | 1 | 5 |
| Michael Henson | 1 | 5 |
| Anthony Natale | 1 | 4 |
| William Olson | 1 | 3 |
| Peter Van Der Sluis | 1 | 3 |
| Eric Kanowsky | 1 | 3 |
| Martha Temple | 1 | 3 |
| Anurag Kondapalli | 1 | 3 |
| Adam Halpern-Leistner | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.